Optivar
Blepharitis allergic, Rhinitis, Vasomotor, Hay Fever + 6 more
Treatment
1 Active Study for Optivar
Treatment for
Blepharitis allergic
What is Optivar
Azelastine
The Generic name of this drug
Treatment Summary
Azelastine is a medicine used to treat allergies and related conditions. It comes in the form of a nasal spray and an eye drop. Azelastine works by blocking the action of histamine, a chemical released during an allergic reaction. It was approved by the FDA in 1996 and is also available in combination with fluticasone propionate as a nasal spray called Dymista™, which is used to treat seasonal allergies in patients over 6 years old.
Astelin
is the brand name
Optivar Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Astelin
Azelastine
1996
56
Effectiveness
How Optivar Affects Patients
Azelastine stops the effects of histamines, which helps relieve allergy symptoms. When taken intranasally (in the nose), it takes about 15 minutes to take effect, while ophthalmic solutions (eye drops) start working in 3 minutes. Its peak effectiveness occurs 4-6 hours after the first dose, and its effects last for 12 hours.
How Optivar works in the body
Azelastine is a medication used to treat allergies. It works by blocking histamine H1-receptors, which are found on nerve endings, smooth muscle cells, and glandular cells. When these receptors are blocked, the typical symptoms of allergies such as itching, sneezing, and congestion are reduced. Azelastine also has other anti-allergy properties such as stabilizing mast cells to prevent the release of inflammatory substances, and reducing the production and release of eosinophils. Additionally, it can reduce the concentrations of substance P and bradykinin, which are responsible for nasal itching and sne
When to interrupt dosage
The proposed dose of Optivar is contingent upon the determined condition, such as Hay Fever, Disorder of eye and Keratoconjunctivitis. The measure of dosage is contingent on the technique of delivery (e.g. Nasal or Solution/drops) specified in the table hereunder.
Condition
Dosage
Administration
Keratoconjunctivitis
, 0.137 mg, 0.5 mg/mL, 0.2055 mg, 1.37 mg/mL, 1.0 mg/mL, 1.5 mg/mL, 0.137 mg/pump actuation
, Nasal, Spray, metered, Spray, metered - Nasal, Spray, Spray - Nasal, Solution / drops - Ophthalmic, Ophthalmic, Intraocular, Solution / drops - Intraocular, Solution / drops
Administration, Intranasal
, 0.137 mg, 0.5 mg/mL, 0.2055 mg, 1.37 mg/mL, 1.0 mg/mL, 1.5 mg/mL, 0.137 mg/pump actuation
, Nasal, Spray, metered, Spray, metered - Nasal, Spray, Spray - Nasal, Solution / drops - Ophthalmic, Ophthalmic, Intraocular, Solution / drops - Intraocular, Solution / drops
allergic eye disorders
, 0.137 mg, 0.5 mg/mL, 0.2055 mg, 1.37 mg/mL, 1.0 mg/mL, 1.5 mg/mL, 0.137 mg/pump actuation
, Nasal, Spray, metered, Spray, metered - Nasal, Spray, Spray - Nasal, Solution / drops - Ophthalmic, Ophthalmic, Intraocular, Solution / drops - Intraocular, Solution / drops
Rhinitis, Vasomotor
, 0.137 mg, 0.5 mg/mL, 0.2055 mg, 1.37 mg/mL, 1.0 mg/mL, 1.5 mg/mL, 0.137 mg/pump actuation
, Nasal, Spray, metered, Spray, metered - Nasal, Spray, Spray - Nasal, Solution / drops - Ophthalmic, Ophthalmic, Intraocular, Solution / drops - Intraocular, Solution / drops
Blepharitis allergic
, 0.137 mg, 0.5 mg/mL, 0.2055 mg, 1.37 mg/mL, 1.0 mg/mL, 1.5 mg/mL, 0.137 mg/pump actuation
, Nasal, Spray, metered, Spray, metered - Nasal, Spray, Spray - Nasal, Solution / drops - Ophthalmic, Ophthalmic, Intraocular, Solution / drops - Intraocular, Solution / drops
Rhinitis, Allergic
, 0.137 mg, 0.5 mg/mL, 0.2055 mg, 1.37 mg/mL, 1.0 mg/mL, 1.5 mg/mL, 0.137 mg/pump actuation
, Nasal, Spray, metered, Spray, metered - Nasal, Spray, Spray - Nasal, Solution / drops - Ophthalmic, Ophthalmic, Intraocular, Solution / drops - Intraocular, Solution / drops
Allergy to Tree Pollen
, 0.137 mg, 0.5 mg/mL, 0.2055 mg, 1.37 mg/mL, 1.0 mg/mL, 1.5 mg/mL, 0.137 mg/pump actuation
, Nasal, Spray, metered, Spray, metered - Nasal, Spray, Spray - Nasal, Solution / drops - Ophthalmic, Ophthalmic, Intraocular, Solution / drops - Intraocular, Solution / drops
Hay Fever
, 0.137 mg, 0.5 mg/mL, 0.2055 mg, 1.37 mg/mL, 1.0 mg/mL, 1.5 mg/mL, 0.137 mg/pump actuation
, Nasal, Spray, metered, Spray, metered - Nasal, Spray, Spray - Nasal, Solution / drops - Ophthalmic, Ophthalmic, Intraocular, Solution / drops - Intraocular, Solution / drops
Allergic Conjunctivitis (AC)
, 0.137 mg, 0.5 mg/mL, 0.2055 mg, 1.37 mg/mL, 1.0 mg/mL, 1.5 mg/mL, 0.137 mg/pump actuation
, Nasal, Spray, metered, Spray, metered - Nasal, Spray, Spray - Nasal, Solution / drops - Ophthalmic, Ophthalmic, Intraocular, Solution / drops - Intraocular, Solution / drops
Warnings
There are 20 known major drug interactions with Optivar.
Common Optivar Drug Interactions
Drug Name
Risk Level
Description
Astemizole
Major
The metabolism of Astemizole can be decreased when combined with Azelastine.
Axitinib
Major
The metabolism of Axitinib can be decreased when combined with Azelastine.
Brigatinib
Major
The metabolism of Brigatinib can be decreased when combined with Azelastine.
Cabazitaxel
Major
The metabolism of Cabazitaxel can be decreased when combined with Azelastine.
Copanlisib
Major
The metabolism of Copanlisib can be decreased when combined with Azelastine.
Optivar Toxicity & Overdose Risk
Taking too much of an azelastine nasal spray or eye drop is unlikely to lead to serious harm, though it may cause drowsiness. To keep children safe, these products should be kept away from them. In studies, the toxic dose of azelastine in rats was found to be 580mg/kg.
Optivar Novel Uses: Which Conditions Have a Clinical Trial Featuring Optivar?
Nine clinical trials are currently being conducted to assess the potential of Optivar to treat Administration, Intranasal Disorders, Ocular Dysfunctions and Allergic Blepharitis.
Condition
Clinical Trials
Trial Phases
Rhinitis, Vasomotor
1 Actively Recruiting
Not Applicable
Administration, Intranasal
0 Actively Recruiting
Keratoconjunctivitis
0 Actively Recruiting
Hay Fever
0 Actively Recruiting
Allergy to Tree Pollen
0 Actively Recruiting
Allergic Conjunctivitis (AC)
1 Actively Recruiting
Phase 2
Rhinitis, Allergic
0 Actively Recruiting
allergic eye disorders
0 Actively Recruiting
Blepharitis allergic
0 Actively Recruiting
Optivar Reviews: What are patients saying about Optivar?
5
Patient Review
7/29/2010
Optivar for Allergic Conjunctivitis
5
Patient Review
11/7/2010
Optivar for Allergic Conjunctivitis
5
Patient Review
9/25/2013
Optivar for Allergic Conjunctivitis
5
Patient Review
1/19/2009
Optivar for Allergic Conjunctivitis
5
Patient Review
2/18/2010
Optivar for Allergic Conjunctivitis
5
Patient Review
2/21/2008
Optivar for Allergic Conjunctivitis
4.7
Patient Review
10/30/2009
Optivar for Allergic Conjunctivitis
4
Patient Review
4/14/2008
Optivar for Allergic Conjunctivitis
4
Patient Review
5/6/2009
Optivar for Allergic Conjunctivitis
3
Patient Review
12/7/2007
Optivar for Allergic Conjunctivitis
1.7
Patient Review
10/26/2008
Optivar for Allergic Conjunctivitis
Patient Q&A Section about optivar
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the generic name for optivar?
"Azelastine drops are used to treat itching, redness, and watering of the eyes caused by allergies.
Azelastine drops are used to relieve itchiness, redness, and watering of the eyes that are caused by allergies."
Answered by AI
What is optivar eye drops used for?
"Azelastine is a medication used to relieve itching eyes caused by allergies (allergic conjunctivitis). It belongs to a class of drugs known as antihistamines."
Answered by AI
Do you need a prescription for optivar?
"Optivar is a prescription drug given to people suffering from Allergic Conjunctivitis. It may be used by itself or in addition to other drugs. It falls into the category of drugs known as Antihistamines, Ophthalmic. The effects of this drug have not been studied in children under the age of three."
Answered by AI
Can you get optivar over the counter?
"Azelastine requires a prescription and cannot be bought over-the-counter."
Answered by AI